StonvexLoading…
StonvexCore line items from STTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-12 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $1.00M | $1.00M | $0.00 |
Operating Income | Not available | $-15.54M | $-51.51M | $-38.14M | $-27.42M |
Net Income | Not available | $-14.77M | $-48.81M | $-36.22M | $-12.46M |
EPS (Diluted) | $-0.13 | $-0.13 | $-0.70 | $-0.62 | $-0.51 |
Total Assets | Not available | $102.12M | $91.03M | $100.33M | $64.37M |
Total Liabilities | Not available | $6.29M | $8.64M | $7.09M | $7.35M |
Cash & Equivalents | Not available | $90.42M | $54.19M | $42.55M | $50.47M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-39.95M | $-31.46M | $-22.46M |
Shares Outstanding | Not available | 75.58M | 63.28M | 63.15M | 47.90M |